Key facts
- It has raised $43.7M; the latest was Later Stage VC in Feb 2025.
- Notable investors include Cherry Ventures, HBM Partners, Inter-American Development Bank, IDB Invest, Elysia Capital — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Farmalisto
- ·The full record, as it builds
Funding rounds
No funding rounds for Farmalisto are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Farmalisto
Developer of an online pharmacy tech platform designed to facilitate the purchase of medicines focussing on chronic, complex pharmaceuticals. The company offers a platform that showcases pharmaceutical products along with home assistance and laboratory services including patient support programs, enabling patients to have access to medicines in the comfort of their homes or offices.
- Sector
- Healthcare
- HQ
- Bogota, Colombia
- Founded
- 2013
- Employees
- 107
- Website
- farmalisto.com/
- Ownership
- Privately Held (backing)
Farmalisto doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Farmalisto shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Farmalisto in its N-PORT filings yet. We sweep new filings monthly.